(Hypertension. 1995;25:1220-1223.)
© 1995 American Heart Association, Inc.
Articles |
From the Division of Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn.
| Abstract |
|---|
|
|
|---|
Key Words: sodium nitric oxide endothelium vasodilation
| Introduction |
|---|
|
|
|---|
Several studies in animals indicate that NO plays a role in the regulation of the blood pressure response to sodium loading. In Sprague-Dawley rats, a high salt intake enhanced NO synthesis, as determined by the urinary excretion of nitrates and nitrites,11 and in dogs receiving a high sodium diet, inhibition of NO synthesis resulted in elevated arterial pressure and attenuation of both natriuresis and diuresis.12 When salt-sensitive and salt-resistant Dahl/Rapp rats received a high salt diet, the salt-sensitive strain produced less NO than the salt-resistant strain and became hypertensive, whereas the salt-resistant strain remained normotensive. However, L-arginine administration to the salt-sensitive strain, under similar conditions of salt loading, enhanced NO production to a level similar to that of the salt-resistant strain and prevented the development of hypertension.13 These studies suggest that salt loading in normotensive animals results in enhanced NO production and may alter NO-mediated responses, regulate natriuresis, and protect against the development of hypertension. Furthermore, in salt-sensitive strains, deficient NO production under conditions of salt loading may result in the development of hypertension. The relevance of these findings to humans is unclear; therefore, in this study we determined whether NO-mediated vasodilation was altered by sodium intake in normotensive subjects by examining forearm blood flow (FBF) responses to the endothelium-dependent agonist methacholine and the endothelium-independent agonist sodium nitroprusside.
| Methods |
|---|
|
|
|---|
Experimental Protocol
Subjects were studied on two occasions, 4 weeks apart, with
identical procedures followed on each study day. For 5 days before each
study day, subjects were maintained on a diet containing either 10 or
250 mmol Na+ per 24 hours. The diet was prepared by the
metabolic kitchen of the Vanderbilt Clinical Research Center under the
supervision of a dietitian. The order of administration of the low or
high sodium diet was randomized. To demonstrate that sodium balance had
been attained, 24-hour urinary sodium excretion was determined in
samples collected on the fifth day of both low and high sodium diets.
All experiments were performed in the morning, in the same
temperature-controlled room, by the same investigators, with the
subjects resting supine in bed. An intravenous cannula was placed in an
antecubital vein of both arms. After subdermal administration of 1%
lidocaine, an 18-gauge polyurethane catheter (Cook Inc) was inserted
into the brachial artery of the nondominant arm, allowing direct
intra-arterial drug administration. Arterial catheter patency was
maintained with an infusion of 40 mL/h of 5% dextrose in water. During
intra-arterial drug administration, the total flow rate through the
cannula was maintained constant at 40 mL/h by altering the
concentration of the drug infusion. Arterial blood pressure was
measured by means of a pressure transducer (Hewlett-Packard), and heart
rate was recorded from a continuous electrocardiograph monitor. After
the arterial line and intravenous catheters had been placed, subjects
rested quietly for 30 minutes before baseline measurements were
determined. Venous blood samples for renin determination were collected
in chilled tubes containing EDTA, centrifuged at 4°C, separated
immediately, and stored at -20°C until analyzed. Arterial blood
samples for determination of norepinephrine concentrations were
collected in cooled tubes with EGTA and reduced glutathione (Amersham
Corp), placed on ice, centrifuged at 4°C, stored, and later assayed
in duplicate, as described below.
Methacholine and sodium nitroprusside were infused intra-arterially in incremental doses (0.25 to 8 µg/min) with an infusion pump (Harvard Apparatus). Each dose was infused for 5 minutes, with FBF measurements made during the last 2 minutes of each infusion. The order of methacholine and sodium nitroprusside administration was randomized between subjects, but each subject received these two drugs in the same order on the 2 study days. A 30-minute washout period between the infusion of the two drugs allowed blood flow to return to baseline before infusion of the second drug.
Forearm Blood Flow
FBF was measured in the arm into which intra-arterial
vasodilators were infused with the use of mercury-in-Silastic
strain-gauge plethysmography.14 The wrist was supported in
a sling so the level of the forearm was raised above that of the
atrium. The hand was excluded from the measurement of blood flow by
inflation of a pediatric sphygmomanometer cuff to 200 mm Hg around the
wrist before and during FBF measurement. Forearm volume, excluding the
hand and wrist, was measured by water displacement. Blood flow tracings
were analyzed manually by a single investigator who was blinded to
sodium intake on the different study days.
Assays
Plasma renin activity was determined by generation of
angiotensin I (Ang I) measured by radioimmunoassay.15
Norepinephrine concentrations were measured by high-performance liquid
chromatography with electrochemical detection and
3,4-dihydroxybenzylamine as the internal standard as described
previously16 17 ; urinary sodium concentrations were
measured by flame photometer.
Data Analysis
Data are expressed as mean±SEM and were analyzed by
repeated-measures ANOVA or Student's t test for paired data
as appropriate. A value of P<.05 was accepted as the
minimal level of significance.
| Results |
|---|
|
|
|---|
|
Mean FBF responses to methacholine (Fig 1) were not altered by sodium intake (F=0.57, P=.48); however, responses to sodium nitroprusside (Fig 2) were enhanced when subjects received a high sodium diet (F=7.11, P<.05).
|
|
| Discussion |
|---|
|
|
|---|
Several studies in animals suggest that dietary sodium intake may modulate NO production. Exposure of rats to a high salt intake resulted in increased concentrations of plasma and urinary nitrates and nitrites, products of NO metabolism,11 and compared with controls, the chronically salt-loaded rats demonstrated enhanced renal hemodynamic responses to inhibition of NO synthase,11 suggesting that the endogenous NO system modulates renal hemodynamics and participates in the physiological adaptation to increased salt intake. The possibility that impaired NO synthesis contributed to the pathogenesis of salt-sensitive hypertension was suggested by studies demonstrating that increased dietary salt intake resulted in increased NO production in salt-resistant but not salt-sensitive rats and that administration of L-arginine, the precursor of NO, resulted in increased NO production and prevention of hypertension in salt-sensitive rats.13 18 These studies therefore suggested that the normal response to salt loading was an increase in NO production and that salt-sensitive hypertension developed in rat strains in which this response was impaired.
Sodium intake has been found to influence NO-mediated vascular responses in addition to modulation of NO production. Boegehold19 found that high salt intake resulted in impaired vasodilation in response to acetylcholine in the arcade arterioles but not in the smaller transverse and distal arterioles in the spinotrapezius muscle microvasculature of salt-sensitive but not salt-resistant Dahl rats. Responses to sodium nitroprusside were not altered, suggesting that the effect of salt was not due to altered smooth muscle responsiveness to NO.19
In the present study sodium intake did not influence the methacholine-induced increase in FBF. Acetylcholine and methacholine, endothelium-dependent vasodilators, are thought to act on endothelial muscarinic receptors, resulting in the activation of NO synthase, which stimulates NO production from L-arginine.1 20 In contrast, sodium nitroprusside, an endothelium-independent vasodilator, is thought to release NO directly through poorly understood mechanisms.1 20 The demonstration of membrane-associated, sodium nitroprussidedirected, NO-generating activity in bovine coronary artery smooth muscle subcellular fractions21 and of NO release from sodium nitroprusside after reaction with thiols, reducing agents, hemoglobin, myoglobin, and partially purified cytochrome P-45022 suggests that the production of NO from sodium nitroprusside in biological tissue is complex and not caused by spontaneous degradation, as was previously thought. Therefore, although both methacholine and sodium nitroprusside activate soluble guanylate cyclase through NO to produce smooth muscle relaxation and vasodilation, they produce NO by different mechanisms.
We used sodium nitroprusside and methacholine in the present study so that we could define the site of any abnormality in NO responsiveness. The finding of increased sensitivity to sodium nitroprusside during high sodium intake, in the face of an unaltered response to methacholine, would not exclude the possibility that sodium loading might result in increased vascular reactivity to NO (as shown by the sodium nitroprusside response) if the unaltered response to methacholine could be accounted for by an inhibitory effect of high sodium intake on endothelium-dependent NO synthesis after methacholine administration. An alternative interpretation is that the vascular response to NO was unaltered by sodium status and that the enhanced response observed after sodium nitroprusside administration while subjects received a high sodium diet was due to enhanced endothelium-independent generation of NO from sodium nitroprusside during conditions of high salt intake.
It is difficult to exclude the possibility of a sodium-induced alteration in drug clearance, or at least local drug clearance in the forearm. However, the strength of the technique of agonist delivery directly into the arterial system under investigation is that it provides the advantage of the delivery of an exact drug dose into the vascular bed whose response is being determined; for this reason the technique has been used extensively for the study of the regulation of vascular tone.6 7 8 9 10 However, it is possible that sodium intake may alter local NO degradation. Another possibility is that the interday variability in the methacholine responses was greater than that of the sodium nitroprusside response, obscuring an effect of sodium intake on the response to methacholine. We do not have data on the interday variability of methacholine or nitroprusside responses in individuals studied twice while on the same sodium intake, but the variance for methacholine and sodium nitroprusside responses in the present study was similar, suggesting that greater variability in the responses to methacholine is unlikely to account for our findings.
Modulation of FBF by altered sodium intake has been observed when isoproterenol, a drug that stimulates adenylate cyclase through ß-receptors, was used to examine the effects of sodium intake on ß-receptormediated responses.23 Naslund and colleagues23 found that in normotensive but not hypertensive subjects, a high sodium intake resulted in increased sensitivity to isoproterenol-induced vasodilation and that this was accompanied by a parallel increase in the proportion of ß-receptors exhibiting binding in the high-affinity state, suggesting that the observed alterations in responsiveness to isoproterenol were accounted for by alterations in the ß-receptor. However, since the generation of NO from sodium nitroprusside is not thought to be receptor mediated, it is unlikely that mechanisms similar to those thought to account for sodium-induced alterations in ß-receptor responsiveness explain the enhanced response to sodium nitroprusside. However, it is possible that a high sodium intake through a mechanism as yet undetermined results in a generalized enhanced vascular smooth muscle responsiveness to endothelium-independent agonists. Therefore, further studies examining the effects of sodium intake on other endothelium-independent agonists would be of interest. Studies examining the effects of sodium intake on responses to bradykinin and the reactive hyperemia response to ischemia, stimuli acting partially through NO, would also be of interest.
In conclusion, the administration of a high salt diet to normotensive subjects did not alter NO-mediated vascular responsiveness as determined by methacholine-induced increases in FBF; however, responses to sodium nitroprusside were enhanced for reasons that are at present unclear.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received September 7, 1994; first decision October 25, 1994; accepted January 18, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Omland, W. Johnson, M. B. Gordon, and M. A. Creager Endothelial function during stimulation of renin-angiotensin system by low-sodium diet in humans Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2248 - H2254. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bragulat, Alejandro de la Sierra, M. T. Antonio, and A. Coca Endothelial Dysfunction in Salt-Sensitive Essential Hypertension Hypertension, February 1, 2001; 37(2): 444 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Fujiwara, T. Osanai, T. Kamada, T. Katoh, K. Takahashi, and K. Okumura Study on the Relationship Between Plasma Nitrite and Nitrate Level and Salt Sensitivity in Human Hypertension : Modulation of Nitric Oxide Synthesis by Salt Intake Circulation, February 29, 2000; 101(8): 856 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Bech, C. B. Nielsen, P. Ivarsen, K. T. Jensen, and E. B. Pedersen Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans Am J Physiol Renal Physiol, May 1, 1998; 274(5): F914 - F923. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Stein, R. Nelson, H. B. He, M. Wood, and A. J. J. Wood Norepinephrine Release in the Human Forearm : Effects of Epinephrine Hypertension, November 1, 1997; 30(5): 1078 - 1084. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |